New COVID-19 vaccine candidate provides effective option for low- to mid-income countries
(Emory Health Sciences) Combining yeast-expression technology and a novel adjuvant formulation to produce a COVID-19 vaccine candidate is effective against SARS-COV-2 and promises to be easy to produce at large scale and cost-effective, important aspects for vaccinating people worldwide, especially in low- to middle-income countries. Results from the study, which applied lessons learned from the hepatitis b vaccine platform technology, are published online today in Science Immunology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 15, 2021 Category: International Medicine & Public Health Source Type: news
Hepatitis B Virus Monitoring Needed After Liver Transplantation
FRIDAY, July 9, 2021 -- Health care providers should test liver recipients for hepatitis B virus (HBV) given the slight risk for unexpected donor-derived HBV infection, according to research published in the July 9 issue of the U.S. Centers for... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 9, 2021 Category: Pharmaceuticals Source Type: news
Unexpected Hepatitis B Virus Infection After Liver Transplantation - United States, 2014-2019
This report describes donor-derived hepatitis B virus infections after liver transplantation. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - July 8, 2021 Category: American Health Tags: Hepatitis B MMWR Morbidity & Mortality Weekly Report Organ Translplants Source Type: news
Punjab introduces free testing, treatment of Hepatitis B in all govt health institutions
"Hepatitis B samples will be taken at these institutions from the patient free of cost, while the cost of the test will be reimbursed to the lab at the rate of Rs 851 by the state government," he said, as per an official statement. (Source: The Economic Times)
Source: The Economic Times - June 22, 2021 Category: Consumer Health News Source Type: news
A third dose of COVID-19 vaccine increased antibody levels in organ transplant recipients with a sub
(American College of Physicians) A case series published in Annals of Internal Medicine found that a third dose of vaccine increased antibody levels in organ transplant recipients who had suboptimal response to standard vaccination. These findings suggest that clinical trials are warranted to determine whether booster doses should be incorporated into clinical practice for transplant patients, just as they have been for hepatitis B and influenza vaccinations. This is the first study to report on response to a third vaccine dose. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 14, 2021 Category: Infectious Diseases Source Type: news
Two-dose hepatitis B vaccine cost effective versus 3-dose vaccine
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - June 1, 2021 Category: Drugs & Pharmacology Source Type: news
New immunotherapy 'highly effective' against hepatitis B
(University College London) Scientists at UCL have identified a new immunotherapy to combat the hepatitis B virus (HBV), the most common cause of liver cancer in the world. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 14, 2021 Category: International Medicine & Public Health Source Type: news
Treatment Paradigm for Chronic HBV in Flux Treatment Paradigm for Chronic HBV in Flux
These days deciding when to stop targeted treatment for chronic hepatitis B is a bigger challenge than knowing when to start, Norah A. Terrault, MD, MPH, observed.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - April 3, 2021 Category: Gastroenterology Tags: Gastroenterology News Source Type: news
ART Likely Less Effective in Women With HIV Versus Other Chronic Viral Illnesses ART Likely Less Effective in Women With HIV Versus Other Chronic Viral Illnesses
HIV-infected women who underwent assisted reproductive technology (ART) had a lower live birth rate than those with chronic hepatitis B or hepatitis C virus in a cohort study.Reuters Health Information (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - April 1, 2021 Category: Infectious Diseases Tags: HIV/AIDS News Source Type: news
How DaVita is working to directly administer Covid-19 vaccines to patients across the country
The Denver-based kidney care company is using the processes it developed for flu and Hepatitis B vaccines and applying them to Covid-19. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - March 30, 2021 Category: American Health Authors: Jensen Werley Source Type: news
How DaVita is working to directly administer Covid-19 vaccines to patients across the country
The Denver-based kidney care company is using the processes it developed for flu and Hepatitis B vaccines and applying them to Covid-19. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 30, 2021 Category: Biotechnology Authors: Jensen Werley Source Type: news
Hepatitis B: What people can learn from donkeys
(German Center for Infection Research) The discovery of a previously unknown hepatitis B virus in donkeys and zebras opens up new opportunities for understanding the course of the disease. A global research consortium was able to show that the course of the infection with this virus is similar to that of chronic hepatitis B in humans. The study was led by DZIF scientists at the Charit é - Universit ä tsmedizin Berlin and the Justus Liebig University Giessen. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 17, 2021 Category: International Medicine & Public Health Source Type: news
New study provides detailed view of how hepatitis B virus establishes chronic infection
(Princeton University) Researchers identified five proteins that are necessary for hepatitis B virus infection, which kills more than 850,000 people worldwide each year and has no cure. The research on the viral life cycle could eventually help identify drugs that block infection. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 11, 2021 Category: International Medicine & Public Health Source Type: news
Venatorx adds potential chronic hepatitis B treatment to its pipeline
A Chester County pharmaceutical company said Wednesday it has selected a clinical candidate it intends to develop as a treatment for chronic hepatitis B virus infections.
Venatorx Pharmaceuticals, an antibiotic developer that was founded in 2010 and is based in Malvern, has long had hepatitis B on its list of targets.
An estimated 200,000 new cases of hepatitis B, a serious liver infection, are diagnosed in the U.S each year. More than 250 million people worldwide have chronic hepatitis B.
Venatorx's… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - March 10, 2021 Category: American Health Authors: John George Source Type: news
Ghana: Stakeholders Call for Hepatitis B, Malaria Testing Guidelines
[Ghanaian Times] Stakeholders at a Hepatitis B and Malaria (HEPMAL) workshop yesterday called for a National Testing Guidelines for the eradication of Hepatitis B and Malaria. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - March 8, 2021 Category: Infectious Diseases Source Type: news
